Form 4: Oncology Institute Executive Sells Shares
Insider Transaction (Form 4)
Yale Podnos, Chief Medical Officer of Oncology Institute, Inc., sold 23,452 shares of common stock on July 14, 2026.
Summary
- Option exercise/conversion: acquired 17,974 Common Stock at $1.87 ($33,611) on July 14, 2026; holds 277,501 after (Direct).
- Open-market sale: disposed of 17,974 Common Stock at $6.43 ($115,555) on July 14, 2026; holds 259,527 after (Direct).
- Option exercise/conversion: acquired 5,478 Common Stock at $2.00 ($10,956) on July 14, 2026; holds 265,005 after (Direct).
- Open-market sale: disposed of 5,478 Common Stock at $6.35 ($34,785) on July 14, 2026; holds 259,527 after (Direct).
- Option exercise/conversion: acquired 17,974 Stock Option (Right to Buy) at $1.87 ($33,611) on July 14, 2026 (Direct).
- Option exercise/conversion: acquired 5,478 Stock Option (Right to Buy) at $2.00 ($10,956) on July 14, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $150,340 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Yale Podnos — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Option exercise/conversion | Common Stock | 17,974 | $2 | $33.6K | 277,501 |
| 2026-07-14 | Open-market sale | Common Stock | 17,974 | $6 | $115.6K | 259,527 |
| 2026-07-14 | Option exercise/conversion | Common Stock | 5,478 | $2 | $11.0K | 265,005 |
| 2026-07-14 | Open-market sale | Common Stock | 5,478 | $6 | $34.8K | 259,527 |
| 2026-07-14 | Option exercise/conversion | Stock Option (Right to Buy) | 17,974 | $2 | $33.6K | 0 |
| 2026-07-14 | Option exercise/conversion | Stock Option (Right to Buy) | 5,478 | $2 | $11.0K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Option exercise/conversion (17,974 shares) |
| 2026-07-14 | Open-market sale (17,974 shares) |
| 2026-07-14 | Option exercise/conversion (5,478 shares) |
| 2026-07-14 | Open-market sale (5,478 shares) |
| 2026-07-14 | Option exercise/conversion (17,974 shares) |
| 2026-07-14 | Option exercise/conversion (5,478 shares) |
Keywords
insider transaction, Form 4, TOI, Oncology Institute, Inc., bearish, Yale Podnos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.